Edwards Lifesciences Corporation reported unaudited consolidated earnings results for the fourth quarter and year ended December 31, 2018. For the quarter, net sales were $977.7 million against $888.5 million a year ago. Operating loss was $5.3 million against income of $336.1 million a year ago. Net income was $7.0 million against loss of $2.8 million a year ago. Basic earnings per share were $0.03 against loss of $0.01 a year ago. For the year, net sales were $3,722.8 million against $3,435.3 million a year ago. Operating income was $748.2 million against $1,089.4 million a year ago. Net income was $722.2 million against $583.6 million a year ago. Basic earnings per share were $3.45 against $2.77 a year ago. Diluted earnings per share were $3.38 against $2.70 a year ago.